Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about AWKNF Recent news which mentions AWKNF < Previous 1 2 3 Next > Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More April 17, 2024 Tickers AWKNF BETRF CMND FLHLF Tags Psychedelics Reform MDXXF Psychedelics Research From Benzinga Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More February 15, 2024 Tickers ATAI AWKNF CMND CYBN Tags CMND Market News MYCOF From Benzinga Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More January 26, 2024 Tickers AWKNF CMND CMPS FLHLF Tags SEEL CMND PSYGF From Benzinga Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More December 27, 2023 Tickers ATAI AWKNF CMND CMPS Tags Psychedelics President Biden CMPS From Benzinga Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation December 21, 2023 Tickers AWKNF Tags Cannabis Market News Markets From Benzinga Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More November 24, 2023 Tickers ATAI AWKNF CMPS CYBN Tags Psychedelic/Assisted Therapies CMPS CYBN From Benzinga UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center November 15, 2023 Tickers AWKNF CMPS Tags Markets severe alcohol use disorder Market News From Benzinga U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy October 15, 2023 Tickers AWKNF Tags Psychedelic/Assisted Therapies Drug Science ScholarGPS From Benzinga Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More September 11, 2023 Tickers ATAI AWKNF CMND CMPS Tags SPRC Psychedelics CYBN From Benzinga Awakn Life Sciences Submits CTA For Phase III Alcohol Use Disorder Clinical Trial September 06, 2023 Tickers AWKNF Tags Benzinga Psychedelics AWKNF From Benzinga Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More August 14, 2023 Tickers AGNPF ATAI AWKNF CMPS Tags IXHL REUN CYBN From Benzinga Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More August 03, 2023 Tickers ATAI AWKNF CMPS CYBN Tags News ATAI GHRS From Benzinga Awakn Life Sciences Becomes Pure R&D Biotech After Sale Of Norway Clinics August 01, 2023 Tickers AWKNF Tags Ketamine Treatment AWKNF Benzinga From Benzinga Awakn Life Sciences On Track With Phase 3 Trial To Research Substance Use Disorder July 26, 2023 Tickers AWKNF Tags contributors AWKNF Benzinga From Benzinga Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More July 11, 2023 Tickers AWKNF CMPS DMTTF FLHLF Tags Psychedelics PMBHF Psychedelic/Assisted Therapies From Benzinga Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next July 05, 2023 Tickers AWKNF Tags Management Psychedelic/Assisted Therapies AWKNF From Benzinga Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement June 15, 2023 Tickers AWKNF Tags News Penny Stocks Global From Benzinga Awakn To Focus On R&D Of Addiction Therapies, Moves Away From Ketamine Treatment For Alcoholism June 12, 2023 Tickers AWKNF Tags R&D Investment AWKNF Benzinga From Benzinga Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More May 01, 2023 Tickers AWKNF IXHL MNMD MSSTF Tags Benzinga Psychedelics AWKNF From Benzinga Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion April 28, 2023 Tickers AWKNF Tags Ketamine/Assisted Therapy Psychedelics Benzinga From Benzinga Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More April 24, 2023 Tickers AWKNF CMND DRUG HUGE Tags Psychedelics Financing MNMD ETFs From Benzinga Severe Alcohol Use Disorder Patients Will Try Ketamine Therapy At Awakn's New Phase 3 Study April 19, 2023 Tickers AWKNF Tags Benzinga Psychedelics AWKNF From Benzinga EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps April 19, 2023 Tickers AWKNF Tags Nick Kadysh Benzinga Psychedelics Capital Conference Courtney Barnes From Benzinga Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More April 17, 2023 Tickers ATAI AWKNF CYBN FLHLF Tags Legal Psychedelic/Assisted Therapies CYBN From Benzinga Awakn's Psychedelics Medical Chief Steps Down, Shifts In Company's Stocks And Ownership April 14, 2023 Tickers AWKNF Tags Cannabis Market News Markets From Benzinga EXCLUSIVE: Ketamine Therapy Provider Nushama Co-Founder On Shifting From A Consciousness Of Blame Into A Space Of Responsibility March 19, 2023 Tickers AWKNF Tags Management AWKNF Interview From Benzinga Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event March 13, 2023 Tickers ATAI AWKNF CYBN DMTTF Tags Penny Stocks Benzinga Psychedelics Capital Conference ATAI From Benzinga Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More March 07, 2023 Tickers AGNPF AWKNF BRAXF CMPS Tags HUGE Benzinga AWKNF From Benzinga MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production March 02, 2023 Tickers AWKNF Tags News Supply Chain AWKNF From Benzinga Latest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In California March 02, 2023 Tickers AWKNF OPTHF Tags Psychedelic/Assisted Therapies Psychedelics Benzinga From Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.